Quotient Biodiagnostics Raises a Fresh $5M

Quotient Biodiagnostics, a transfusion diagnostics business based in Edinburgh, Scotland, has raised $5 million from Quotient CEO Paul Cowan and the healthcare venture capital firm Galen Partners based in Stamford, Conn. Over the past 18 months, Quotient has raised more than $19 million altogether.

North AmericaUSBriefs